TP53 and malignant glioma: Molecular genetic study researchers have confirmed that genetic changes involved in the progression of malignant gliomas include loss of heterozygosity 10 (LOH10), phosphatase and tensin homolog (PTEN), tumor protein p53 (TP53), epidermal growth factor receptor (EGFR) and P16[8].